Abstract
Summary
The global market for Synthetic Genes was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Synthetic Genes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Synthetic Genes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Synthetic Genes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Synthetic Genes include Active Motif, BASF AG, Bayer AG, Cargill Inc., Dow, Glaxosmithkline Plc., Merck KGAA, Novartis Pharma AG and Pfizer, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Synthetic Genes, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Synthetic Genes by region & country, by Type, and by Application.
The Synthetic Genes market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Genes.
Market Segmentation
By Company
Active Motif
BASF AG
Bayer AG
Cargill Inc.
Dow
Glaxosmithkline Plc.
Merck KGAA
Novartis Pharma AG
Pfizer, Inc.
Thermo Fisher Scientific, Inc.
Segment by Type:
Company Order
Local Gene Synthesis
Segment by Application
Alternative Energy
New Material
Artificial Life
Nucleic Acid Vaccine
Biological Medicine
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Synthetic Genes manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Synthetic Genes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Synthetic Genes in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Synthetic Genes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Synthetic Genes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Synthetic Genes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Synthetic Genes include Active Motif, BASF AG, Bayer AG, Cargill Inc., Dow, Glaxosmithkline Plc., Merck KGAA, Novartis Pharma AG and Pfizer, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Synthetic Genes, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Synthetic Genes by region & country, by Type, and by Application.
The Synthetic Genes market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Genes.
Market Segmentation
By Company
Active Motif
BASF AG
Bayer AG
Cargill Inc.
Dow
Glaxosmithkline Plc.
Merck KGAA
Novartis Pharma AG
Pfizer, Inc.
Thermo Fisher Scientific, Inc.
Segment by Type:
Company Order
Local Gene Synthesis
Segment by Application
Alternative Energy
New Material
Artificial Life
Nucleic Acid Vaccine
Biological Medicine
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Synthetic Genes manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Synthetic Genes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Synthetic Genes in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Synthetic Genes Product Introduction
1.2 Global Synthetic Genes Market Size Forecast
1.3 Synthetic Genes Market Trends & Drivers
1.3.1 Synthetic Genes Industry Trends
1.3.2 Synthetic Genes Market Drivers & Opportunity
1.3.3 Synthetic Genes Market Challenges
1.3.4 Synthetic Genes Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Synthetic Genes Players Revenue Ranking (2023)
2.2 Global Synthetic Genes Revenue by Company (2019-2024)
2.3 Key Companies Synthetic Genes Manufacturing Base Distribution and Headquarters
2.4 Key Companies Synthetic Genes Product Offered
2.5 Key Companies Time to Begin Mass Production of Synthetic Genes
2.6 Synthetic Genes Market Competitive Analysis
2.6.1 Synthetic Genes Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Synthetic Genes Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Genes as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Company Order
3.1.2 Local Gene Synthesis
3.2 Global Synthetic Genes Sales Value by Type
3.2.1 Global Synthetic Genes Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Synthetic Genes Sales Value, by Type (2019-2030)
3.2.3 Global Synthetic Genes Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Alternative Energy
4.1.2 New Material
4.1.3 Artificial Life
4.1.4 Nucleic Acid Vaccine
4.1.5 Biological Medicine
4.2 Global Synthetic Genes Sales Value by Application
4.2.1 Global Synthetic Genes Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Synthetic Genes Sales Value, by Application (2019-2030)
4.2.3 Global Synthetic Genes Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Synthetic Genes Sales Value by Region
5.1.1 Global Synthetic Genes Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Synthetic Genes Sales Value by Region (2019-2024)
5.1.3 Global Synthetic Genes Sales Value by Region (2025-2030)
5.1.4 Global Synthetic Genes Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Synthetic Genes Sales Value, 2019-2030
5.2.2 North America Synthetic Genes Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Synthetic Genes Sales Value, 2019-2030
5.3.2 Europe Synthetic Genes Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Synthetic Genes Sales Value, 2019-2030
5.4.2 Asia Pacific Synthetic Genes Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Synthetic Genes Sales Value, 2019-2030
5.5.2 South America Synthetic Genes Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Synthetic Genes Sales Value, 2019-2030
5.6.2 Middle East & Africa Synthetic Genes Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Synthetic Genes Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Synthetic Genes Sales Value
6.3 United States
6.3.1 United States Synthetic Genes Sales Value, 2019-2030
6.3.2 United States Synthetic Genes Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Synthetic Genes Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Synthetic Genes Sales Value, 2019-2030
6.4.2 Europe Synthetic Genes Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Synthetic Genes Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Synthetic Genes Sales Value, 2019-2030
6.5.2 China Synthetic Genes Sales Value by Type (%), 2023 VS 2030
6.5.3 China Synthetic Genes Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Synthetic Genes Sales Value, 2019-2030
6.6.2 Japan Synthetic Genes Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Synthetic Genes Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Synthetic Genes Sales Value, 2019-2030
6.7.2 South Korea Synthetic Genes Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Synthetic Genes Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Synthetic Genes Sales Value, 2019-2030
6.8.2 Southeast Asia Synthetic Genes Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Synthetic Genes Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Synthetic Genes Sales Value, 2019-2030
6.9.2 India Synthetic Genes Sales Value by Type (%), 2023 VS 2030
6.9.3 India Synthetic Genes Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Active Motif
7.1.1 Active Motif Profile
7.1.2 Active Motif Main Business
7.1.3 Active Motif Synthetic Genes Products, Services and Solutions
7.1.4 Active Motif Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.1.5 Active Motif Recent Developments
7.2 BASF AG
7.2.1 BASF AG Profile
7.2.2 BASF AG Main Business
7.2.3 BASF AG Synthetic Genes Products, Services and Solutions
7.2.4 BASF AG Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.2.5 BASF AG Recent Developments
7.3 Bayer AG
7.3.1 Bayer AG Profile
7.3.2 Bayer AG Main Business
7.3.3 Bayer AG Synthetic Genes Products, Services and Solutions
7.3.4 Bayer AG Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.3.5 Cargill Inc. Recent Developments
7.4 Cargill Inc.
7.4.1 Cargill Inc. Profile
7.4.2 Cargill Inc. Main Business
7.4.3 Cargill Inc. Synthetic Genes Products, Services and Solutions
7.4.4 Cargill Inc. Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.4.5 Cargill Inc. Recent Developments
7.5 Dow
7.5.1 Dow Profile
7.5.2 Dow Main Business
7.5.3 Dow Synthetic Genes Products, Services and Solutions
7.5.4 Dow Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.5.5 Dow Recent Developments
7.6 Glaxosmithkline Plc.
7.6.1 Glaxosmithkline Plc. Profile
7.6.2 Glaxosmithkline Plc. Main Business
7.6.3 Glaxosmithkline Plc. Synthetic Genes Products, Services and Solutions
7.6.4 Glaxosmithkline Plc. Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.6.5 Glaxosmithkline Plc. Recent Developments
7.7 Merck KGAA
7.7.1 Merck KGAA Profile
7.7.2 Merck KGAA Main Business
7.7.3 Merck KGAA Synthetic Genes Products, Services and Solutions
7.7.4 Merck KGAA Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.7.5 Merck KGAA Recent Developments
7.8 Novartis Pharma AG
7.8.1 Novartis Pharma AG Profile
7.8.2 Novartis Pharma AG Main Business
7.8.3 Novartis Pharma AG Synthetic Genes Products, Services and Solutions
7.8.4 Novartis Pharma AG Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.8.5 Novartis Pharma AG Recent Developments
7.9 Pfizer, Inc.
7.9.1 Pfizer, Inc. Profile
7.9.2 Pfizer, Inc. Main Business
7.9.3 Pfizer, Inc. Synthetic Genes Products, Services and Solutions
7.9.4 Pfizer, Inc. Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.9.5 Pfizer, Inc. Recent Developments
7.10 Thermo Fisher Scientific, Inc.
7.10.1 Thermo Fisher Scientific, Inc. Profile
7.10.2 Thermo Fisher Scientific, Inc. Main Business
7.10.3 Thermo Fisher Scientific, Inc. Synthetic Genes Products, Services and Solutions
7.10.4 Thermo Fisher Scientific, Inc. Synthetic Genes Revenue (US$ Million) & (2019-2024)
7.10.5 Thermo Fisher Scientific, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Synthetic Genes Industrial Chain
8.2 Synthetic Genes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Synthetic Genes Sales Model
8.5.2 Sales Channel
8.5.3 Synthetic Genes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer